Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$2.37 - $4.63 $401,506 - $784,377
-169,412 Reduced 41.05%
243,287 $632,000
Q2 2023

Aug 14, 2023

BUY
$3.47 - $5.33 $217,565 - $334,185
62,699 Added 17.91%
412,699 $1.93 Million
Q1 2023

May 15, 2023

BUY
$3.03 - $5.13 $1.06 Million - $1.8 Million
350,000 New
350,000 $1.32 Million

Others Institutions Holding FUSN

About Fusion Pharmaceuticals Inc.


  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.